drugset / Trial / NCT00239798

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

NCT00239798

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of FTY720 combined with cyclosporine and corticosteroids in patients receiving a kidney transplant.

Timeline

Start
2004-11
Primary completion
2006-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Fingolimod Small molecule 2.5 mg
Subject Fingolimod Small molecule 5 mg

Indications

No indication recorded.